首页> 外国专利> ANHYDROUS AND HYDRATE FORMS OF CRYSTALLINE 2- ( (2S, 3R, 4E, 6E, 1OE, 12S) -13- (4-FLUOROPHENOXY)-2,3,12- (TRIHYDROXYTRIDECA-4, 6, 10-TRIEN-8-YNYL)OXY) ACETIC ACID

ANHYDROUS AND HYDRATE FORMS OF CRYSTALLINE 2- ( (2S, 3R, 4E, 6E, 1OE, 12S) -13- (4-FLUOROPHENOXY)-2,3,12- (TRIHYDROXYTRIDECA-4, 6, 10-TRIEN-8-YNYL)OXY) ACETIC ACID

机译:结晶2-((2S,3R,4E,6E,1OE,12S)-13-(4-氟苯氧基)-2,3,12-(三羟基己基癸酸酯-4,6,10-TRIEN-8- YNYL)OXY)乙酸

摘要

R1 is -0-, -S(0)t- (where t is 0, 1 or 2), or a straight or branched alkylene chain; and R2 is aryl (optionally substituted by one or more substituents selected from alkyl, alkoxy, halo, haloalkyl and haloalkoxy) or aralkyl (optionally substituted by one or more substituents selected from f alkyl, alkoxy, halo, haloalkyl and haloalkoxy); and wherein the compound of Formula (II) is a single stereoisomer or any mixture of stereoisomers. This crystalline acid is useful in treating disease-states characterized by inflammation, such as inflammatory and autoimmune disorders or pulmonary or respiratory tract inflammations in humans. Methods of preparing the crystalline acid are also described.
机译:R1为-0-,-S(0)t-(其中t为0、1或2)或直链或支链亚烷基链; R 2是芳基(任选地被一个或多个选自烷基,烷氧基,卤素,卤代烷基和卤代烷氧基的取代基取代)或芳烷基(任选地被一个或多个选自f烷基,烷氧基,卤素,卤代烷基和卤代烷氧基的取代基取代);其中式(II)的化合物是单一的立体异构体或立体异构体的任何混合物。该结晶酸可用于治疗以炎症为特征的疾病状态,例如人类的炎症和自身免疫疾病或肺或呼吸道炎症。还描述了制备结晶酸的方法。

著录项

  • 公开/公告号IN2010DN08522A

    专利类型

  • 公开/公告日2012-03-02

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN8522/DELNP/2010

  • 申请日2010-12-01

  • 分类号C07C59/125;A61P9/10;A61P11/08;A61P19/02;A61P27/16;A61P1/02;C07C59/66;A61P9/12;A61P1;A61P31/04;A61P17/06;A61K31/19;A61P25/06;A61P11/06;A61P11;A61P37/06;C07C59/13;A61P25/28;A61P31;A61P27/02;A61P11/02;A61P35;A61K31/192;A61P25/16;A61P13/12;A61P13/08;A61P1/04;A61P25;A61P35/02;A61P9;A61P37/08;C07C59/135;A61P43;A61P17;A61P37/02;A61P3/10;A61P29;A61P37;

  • 国家 IN

  • 入库时间 2022-08-21 17:24:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号